Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)
Central sleep apnoea (CSA) is a sleep disorder characterized by the repeated cessation or reduction of both airflow and ventilatory effort when sleeping. Individuals with central breathing disorders have difficulty in receiving appropriate medical treatment. In this article, we describe a case study...
Main Authors: | Abdulmajeed M Albadi, Mana M Alshahrani, Riyad O Allehebi |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2023-11-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/sleep-related-breathing-disorder-central-sleep-apnoea-improved-coincidentally-by-medical-therapy-with-fumarates-dimethyl-fumarate/ |
Similar Items
-
Treatment‐emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: A case report
by: Chin Tong Kwok, et al.
Published: (2022-04-01) -
Peripheral arterial tonometry versus polysomnography in suspected obstructive sleep apnoea
by: Jonathan Röcken, et al.
Published: (2023-07-01) -
3D detection of the central sleep apnoea syndrome
by: Garn Heinrich, et al.
Published: (2017-09-01) -
OBSTRUCTIVE SLEEP APNOEA IN CHILDREN
by: Nina Božanić Urbančič
Published: (2020-09-01) -
Ankyloglossia in Children, a Cause of Obstructive Sleep Apnoea: Case Report of Paediatric Ankyloglossia and Sleep Apnoea: DISE Resolves the Mystery
by: Johanna Ximena Valderrama-Penagos, et al.
Published: (2024-02-01)